425
Views
4
CrossRef citations to date
0
Altmetric
Assessment Procedures

Developing and validating equations to predict V˙O2 peak from the 6MWT in Childhood ALL Survivors

, ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 2937-2944 | Received 16 Oct 2019, Accepted 29 Jan 2020, Published online: 11 Feb 2020

References

  • Ellison L, Janz T. Incidence du cancer et mortalité par cancer chez les enfants au Canada. Statistique Canada, Coup D’oeil Sur la Santé; 2015. p. 82–624.
  • Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–1669.
  • Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–2381.
  • Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582.
  • Lemay V, Caru M, Samoilenko M, et al. Prevention of long-term adverse health outcomes with cardiorespiratory fitness and physical activity in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol. 2019;41(7):e450–e458.
  • Fresneau B, Fayech C, Butel T, et al. Treatment-related cardiotoxicity in childhood cancer survivors: risk factors and follow-up. Rev Med Interne. 2017;38(2):125–132.
  • Lipshultz SE, Adams MJ, Colan SD, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128(17):1927–1995.
  • Raj S, Franco VI, Lipshultz SE. Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment. Curr Treat Options Cardiovasc Med. 2014;16(6):315
  • Caru M, Corbin D, Perie D, et al. Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors. Clin Res Cardiol. 2019;108(9):1000–1008.
  • Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23(12):2629–2636.
  • Hung SH, Rankin A, Virji-Babul N, et al. Associating physical activity levels with motor performance and physical function in childhood survivors of acute lymphoblastic leukemia. Physiother Can. 2017;69(1):57–64.
  • van Brussel M, Takken T, Lucia A, et al. Is physical fitness decreased in survivors of childhood leukemia? A systematic review. Leukemia. 2005;19(1):13–17.
  • Tonorezos ES, Snell PG, Moskowitz CS, et al. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(8):1358–1364.
  • Caru M, Samoilenko M, Drouin S, et al. Childhood acute lymphoblastic leukemia survivors have a substantially lower cardiorespiratory fitness level than healthy Canadians despite a clinically equivalent level of physical activity. J Adolesc Young Adult Oncol. 2019;8(6):674–683.
  • Powell AW, Jefferies JL, Hopkin RJ, et al. Cardiopulmonary fitness assessment on maximal and submaximal exercise testing in patients with Fabry disease. Am J Med Genet A. 2018;176(9):1852–1857.
  • Ness KK, Hudson MM, Pui CH, et al. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer. 2012;118(3):828–838.
  • Hooke MC, Garwick AW, Neglia JP. Assessment of physical performance using the 6-minute walk test in children receiving treatment for cancer. Cancer Nurs. 2013;36(5):E9–E16.
  • Bartels B, de Groot JF, Terwee CB. The six-minute walk test in chronic pediatric conditions: a systematic review of measurement properties. Phys Ther. 2013;93(4):529–541.
  • Rostagno C, Gensini GF. Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure. Intern Emerg Med. 2008;3(3):205–212.
  • Jalili M, Nazem F, Sazvar A, et al. Prediction of maximal oxygen uptake by six-minute walk test and body mass index in healthy boys. J Pediatr. 2018;200:155–159.
  • Ross RM, Murthy JN, Wollak ID, et al. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm Med. 2010;10(1):31.
  • Schumacher AN, Shackelford D, Brown JM, et al. Validation of the six-minute walk test for predicting peak VO2 in cancer survivors. Med Sci Sports Exerc. 2018;51(2):271–277.
  • Silverman LB, Stevenson KE, O'Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia. 2010;24(2):320–334.
  • Marcoux S, Drouin S, Laverdiere C, et al. The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer. 2017;64(6):1–8.
  • Butland RJ, Pang J, Gross ER, et al. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982;284(6329):1607–1608.
  • Thiel TA. The validity and reliability of the Borg rating of perceived exertion scale during aerobic exercise. Boston (MA): Northeastern University; 1986.
  • Bar-Or O, Rowland TW. Pediatric exercise medicine: from physiologic principles to health care application. Champaign (IL): Human Kinetics; 2004.
  • Guazzi M, Adams V, Conraads V, et al. EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126(18):2261–2274.
  • Taylor HL, Jacobs DR Jr., Schucker B, et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31(12):741–755.
  • Kriska AM, Caspersen CJ. Introduction to a collection of physical activity questionnaires. Med Sci Sports Exerc. 1997;29(6):5–9.
  • Montoye HJ. Estimation of habitual physical activity by questionnaire and interview. Am J Clin Nutr. 1971;24(9):1113–1118.
  • Ridley K, Ainsworth BE, Olds TS. Development of a compendium of energy expenditures for youth. Int J Behav Nutr Phys Act. 2008;5(1):45–48.
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310.
  • Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5):1384–1387.
  • Tomiyama AJ, Hunger JM, Nguyen-Cuu J, et al. Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005–2012. Int J Obes. 2016;40(5):883–886.
  • Cahalin LP, Mathier MA, Semigran MJ, et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 1996;110(2):325–332.
  • American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. Baltimore (MD): Lippincott Williams & Wilkins; 2013.
  • Guazzi M, Dickstein K, Vicenzi M, et al. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail. 2009;2(6):549–555.
  • Prescher S, Schoebel C, Koehler K, et al. Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure: a pre-specified sub-study of the TIM-HF-Trial. Eur J Prev Cardiolog. 2016;23(2_suppl):21–26.
  • Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The. N Engl J Med. 2004;350(10):1005–1012.
  • Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. Copd. 2005;2(1):125–129.
  • Hartman A, Hop W, Takken T, et al. Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(3):494–499.
  • Kim S, Song IC, Jee S. Cardiopulmonary exercise test in leukemia patients after chemotherapy: a feasibility study. Ann Rehabil Med. 2017;41(3):456–464.
  • Fulbright JM, Raman S, McClellan WS, et al. Late effects of childhood leukemia therapy. Curr Hematol Malig Rep. 2011;6(3):195–205.
  • Nathan PC, Wasilewski-Masker K, Janzen LA. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(5):1065–1082, vi-vii.
  • Campbell G, Wolfe RA, Klem ML. Risk factors for falls in adult cancer survivors: an integrative review. Rehabil Nurs. 2018;43(4):201–213.
  • Stone DB, Tamburro G, Fiedler P, et al. Automatic removal of physiological artifacts in EEG: the optimized fingerprint method for sports science applications. Front Hum Neurosci. 2018;12:96
  • Shephard RJ, Allen C, Benade A, et al. The maximum oxygen intake: an international reference standard of cardio-respiratory fitness. Bull World Health Organ. 1968;38(5):757.
  • Skender S, Ose J, Chang-Claude J, et al. Accelerometry and physical activity questionnaires – a systematic review. BMC Public Health. 2016;16(1):515.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.